GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Noul Co Ltd (XKRX:376930) » Definitions » COGS-to-Revenue

Noul Co (XKRX:376930) COGS-to-Revenue : 0.92 (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Noul Co COGS-to-Revenue?

Noul Co's Cost of Goods Sold for the three months ended in Mar. 2024 was ₩26 Mil. Its Revenue for the three months ended in Mar. 2024 was ₩29 Mil.

Noul Co's COGS to Revenue for the three months ended in Mar. 2024 was 0.92.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Noul Co's Gross Margin % for the three months ended in Mar. 2024 was 8.48%.


Noul Co COGS-to-Revenue Historical Data

The historical data trend for Noul Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noul Co COGS-to-Revenue Chart

Noul Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
- 0.70 0.74 0.99 0.97

Noul Co Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.89 0.98 1.00 0.98 0.92

Noul Co COGS-to-Revenue Calculation

Noul Co's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=2648.712 / 2733.841
=0.97

Noul Co's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=26.472 / 28.924
=0.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Noul Co  (XKRX:376930) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Noul Co's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 26.472 / 28.924
=8.48 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Noul Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Noul Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Noul Co (XKRX:376930) Business Description

Traded in Other Exchanges
N/A
Address
B-10F, 338, Gwanggyojungang-ro, Suji-gu, Gyeonggi-do, Yongin-si, KOR, 16942
Noul Co Ltd provides solutions for chronic and systemic problems in healthcare. The company's miLab is an all-in-one, fully-automated device which can process sample preparation and AI diagnostic in one workflow. It integrates technologies from computer vision AI, bio, hardware, and software engineering.

Noul Co (XKRX:376930) Headlines

No Headlines